These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12927392)

  • 41. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients.
    Muankaew C; Jansook P; Stefánsson E; Loftsson T
    Int J Pharm; 2014 Oct; 474(1-2):80-90. PubMed ID: 25128698
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin.
    Tommasini S; Calabrò ML; Raneri D; Ficarra P; Ficarra R
    J Pharm Biomed Anal; 2004 Oct; 36(2):327-33. PubMed ID: 15496325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the complexation of diflunisal with hydroxypropyl-beta-cyclodextrin.
    Ugwu SO; Alcala MJ; Bhardwaj R; Blanchard J
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):391-7. PubMed ID: 10704104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of omeprazole with a methylated derivative of beta-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation.
    Figueiras A; Sarraguça JM; Carvalho RA; Pais AA; Veiga FJ
    Pharm Res; 2007 Feb; 24(2):377-89. PubMed ID: 17177111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers.
    Alvarez C; Calero J; Menéndez JC; Torrado S; Torrado JJ
    Pharmazie; 2008 Jul; 63(7):511-3. PubMed ID: 18717484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and physical evaluation of microcapsules of hydrophilic drug-cyclodextrin complexes.
    Loftsson T; Kristmundsdóttir T; Ingvarsdóttir K; Olafsdóttir BJ; Baldvinsdóttir J
    J Microencapsul; 1992; 9(3):375-82. PubMed ID: 1403488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beta-cyclodextrin/steroid complexation: effect of steroid structure on association equilibria.
    Liu FY; Kildsig DO; Mitra AK
    Pharm Res; 1990 Aug; 7(8):869-73. PubMed ID: 2235884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solubilization of cyclosporin A.
    Ran Y; Zhao L; Xu Q; Yalkowsky SH
    AAPS PharmSciTech; 2001 Jan; 2(1):E2. PubMed ID: 14727890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
    Veiga MD; Ahsan F
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inclusion complexation of the sunscreen agent 2-ethylhexyl-p-dimethylaminobenzoate with hydroxypropyl-beta-cyclodextrin: effect on photostability.
    Scalia S; Villani S; Casolari A
    J Pharm Pharmacol; 1999 Dec; 51(12):1367-74. PubMed ID: 10678490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Displacement of Drugs From Cyclodextrin Complexes by Bile Salts: A Suggestion of an Intestinal Drug-Solubilizing Capacity From an In Vitro Model.
    Olesen NE; Westh P; Holm R
    J Pharm Sci; 2016 Sep; 105(9):2640-2647. PubMed ID: 26502027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
    Rawat S; Jain SK
    Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions.
    Loftsson T; Saokham P; Sá Couto AR
    Int J Pharm; 2019 Apr; 560():228-234. PubMed ID: 30771468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
    Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclodextrins in topical drug formulations: theory and practice.
    Loftsson T; Masson M
    Int J Pharm; 2001 Aug; 225(1-2):15-30. PubMed ID: 11489551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined effect of SLS and (SBE)(7M)-beta-CD on the solubilization of NSC-639829.
    Yang G; Jain N; Yalkowsky SH
    Int J Pharm; 2004 Jan; 269(1):141-8. PubMed ID: 14698585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular structures of the inclusion complexes beta-cyclodextrin-1,2-bis(4-aminophenyl)ethane and beta-cyclodextrin-4,4'-diaminobiphenyl; packing of dimeric beta-cyclodextrin inclusion complexes.
    Giastas P; Yannakopoulou K; Mavridis IM
    Acta Crystallogr B; 2003 Apr; 59(Pt 2):287-99. PubMed ID: 12657820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.